A new study suggests the shingles vaccine may reduce the risk of heart disease for up to eight years post-vaccination. A ...

Researchers found people given a shingles vaccine had a 23% lower risk of cardiovascular events, including stroke, heart ...

Research found that shingles vaccines may protect against more than just a painful rash.Fact checked by Nick BlackmerThe ...

A number of states have thus resorted to using the non-live, recombinant Shingrix vaccine, which is more than 90% effective at preventing shingles. GlaxoSmithKline introduced it in 2017 as a ...

A new project will use electronic health data from the UK’s National Health Service to assess the impact of GSK’s shingles ...

The shingles vaccine may offer unexpected protection against heart disease, according to new research published in the European Heart Journal. The comprehensive study found that people receiving the ...

If you've ever had chickenpox in your childhood, chances are you're likely to develop shingles in the future. While people might assume that shingles — a painful, blistering rash — only ...

Recombinant zoster vaccine (RZV) had no significant effect on major adverse cardiovascular events; however, it reduced all-cause mortality in patients with immune-mediated inflammatory diseases ...

It’s since been swapped for Shingrix, a two-shot recombinant zoster vaccine containing only part of the virus — which has shown to be more effective. More research is needed to compare the ...

Studies suggested that Zostavax was 67% effective in the first year but only 50% effective in year 2. It was replaced by Shingrix, a recombinant vaccine that uses a protein from the varicella ...

It’s since been swapped for Shingrix, a two-shot recombinant zoster vaccine containing only part of the virus — which has shown to be more effective.More research is needed to compare the various ...